Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - glucose monohydrate, quantity: 54.99 mg/ml (equivalent: glucose, qty 50 mg/ml) - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 31 july 2000: for fluid and carbohydrate depletion wherever a non-electrolyte fluid is required. in the treatment of hypoglycaemia. in the treatment of acute diarrhoeal disease. as a vehicle for the administration of other medications.

Bèlgica - francès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bioq pharma b.v. - chlorhydrate de ropivacaïne monohydraté 2,116 mg/ml - eq. chlorhydrate de ropivacaïne 2 mg/ml - solution pour perfusion en système d'administration - 2 mg/ml - chlorhydrate de ropivacaïne monohydraté 2.116 mg/ml - ropivacaine

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - refined olive oil + refined soybean oil; alanine; arginine ; aspartic acid; glutamic acid ; glycine; histidine; isoleucine; leucine ; lysine; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine; glucose monohydrate; sodium acetate (as trihydrate); sodium glycerophosphate, hydrated; potassium chloride; magnesium chloride hexahydrate; calcium chloride dihydrate - emulsion for infusion - 7g/l / 1140kcal/l - solutions for parenteral nutrition; combinations

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - isoleucine; leucine ; lysine hydrochloride; methionine; phenylalanine; threonine; tryptophan; valine; arginine monoglutamate ; alanine; aspartic acid; glutamic acid ; glycine; proline; serine; magnesium acetate tetrahydrate; sodium acetate trihydrate ; sodium dihydrogen phosphate dihydrate; potassium hydroxide; sodium hydroxide ; glucose monohydrate; calcium chloride dihydrate; histidine hydrochloride monohydrate - solution for infusion - unknown - solutions for parenteral nutrition; combinations

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - isoleucine; leucine ; lysine hydrochloride; methionine; phenylalanine; threonine; tryptophan; valine; arginine ; histidine hyprochloride monohydrate; alanine; aspartic acid; glutamic acid ; glycine; proline; serine; sodium hydroxide ; sodium chloride; sodium acetate trihydrate ; potassium acetate; magnesium acetate tetrahydrate; calcium chloride dihydrate; glucose monohydrate; sodium dihydrogen phosphate dihydrate; zinc acetate dihydrate; triglycerides, medium chain; soya bean oil, refined; omega-3-acid triglycerides - emulsion for infusion - unknown - solutions for parenteral nutrition; combinations

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; hydrochloric acid; water for injections - indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - l-methionine; potassium chloride; magnesium chloride hexahydrate; calcium chloride dihydrate; glucose anhydrous; olive oil; soya oil; l-alanine; l-arginine; l-aspartic acid; l-glutamic acid; glycine; l-histidine; l-isoleucine; l-leucine; l-lysine; l-phenylalanine; l-proline; l-serine; l-threonine; l-tyrosine; l-valine; sodium acetate trihydrate; l-tryptophan; sodium glycerophosphate hydrate - infusion - 1.26gram/1litre ; 1.19gram/1litre ; 450mg/1litre ; 300mg/1litre ; 75gram/1litre ; 24gram/1litre ; 6gram/1litre ; 3.66gram/1litre ; 2.48gram/1litre ; 730mg/1litre ; 1.26gram/1litre ; 1.76gram/1litre ; 1.51gram/1litre ; 1.26gram/1litre ; 1.76gram/1litre ; 1.99gram/1litre ; 1.76gram/1litre ; 1.51gram/1litre ; 1gram/1litre ; 1.26gram/1litre ; 60mg/1litre ; 1.62gram/1litre ; 1.16gram/1litre ; 420mg/1litre ; 1.91gram/1litre

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - paracetamol, quantity: 1000 mg; ibuprofen sodium dihydrate, quantity: 385 mg (equivalent: ibuprofen, qty 300 mg) - injection, intravenous infusion - excipient ingredients: mannitol; dibasic sodium phosphate dihydrate; cysteine hydrochloride monohydrate; hydrochloric acid; sodium hydroxide; water for injections - maxigesic iv is indicated in adults for the relief of mild to moderate pain and the reduction of fever, where an intravenous route of administration is considered clinically necessary.